Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier
Authors:
- Yun LiYLYun Li
- Tianyu LiuTLTianyu Liu
- Chen YanCYChen Yan
- Runxiang XieRXRunxiang Xie
- Zixuan GuoZGZixuan Guo
- Sinan WangSWSinan Wang
- Yujie ZhangYZYujie Zhang
- Zhengxiang LiZLZhengxiang Li
- Bangmao WangBWBangmao Wang
- Hailong CaoHCHailong Cao
- 23 July 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 15 (9) , 3860-3870
Abstract
Nonalcoholic fatty liver disease (NAFLD), as a common chronic liver disorder, is prevalent in the world. Recent evidence demonstrates that the “gut-liver axis” is related well to the progression of NAFLD, which regards gut microbiota and intestinal barrier as two critical factors correlated with NAFLD. Diammonium glycyrrhizinate (DG), a compound of natural bioactive pentacyclic triterpenoid glycoside, is the main component of licorice roots extracts. The anti-inflammatory and liver protection effects of DG have already been reported, but to date, the mechanism has not been fully elucidated. In this research, we observed that DG reduced body weight, liver steatosis, as well as hepatic inflammatory in NAFLD model mice induced by high fat diet. Illumina sequencing of the 16S rRNA revealed that DG intervention notably altered the composition of the gut microbiota in NAFLD mice. The richness of gut microbiota was significantly increased by DG. Specifically, DG reduced the Firmicutes-to-Bacteroidetes ratio and the endotoxin-producing bacteria such as Desulfovibrio, and elevated the abundance of probiotics such as Proteobacteria and Lactobacillus. Interestingly DG could augment the levels of short-chain fatty acids (SCFAs)-producing bacteria such as Ruminococcaceae and Lachnospiraceae and promote SCFAs production. In addition, DG supplementation dramatically alleviated the intestinal low-grade inflammation. Meanwhile, DG improved the expression of tight junction proteins, the goblet cells number and mucin secretion, and sequentially enhanced the function of intestinal barrier. Collectively, the prevention of NAFLD by DG might be mediated by modulating gut microbiota and restoring intestinal barrier.Keywords
Funding Information
- National Natural Science Foundation of China (81741075)
- China Foundation for Hepatitis Prevention and Control (TQGB20150215)
- Tianjin Research Program of Application Foundation and Advanced Technology (17JCYBJC24900)
- Tianjin Medical University General Hospital (ZYYFY2017020)
This publication has 69 references indexed in Scilit:
- Targeting the Microbiota to Address Diet-Induced Obesity: A Time Dependent ChallengePLOS ONE, 2013
- High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling PathwayPLOS ONE, 2012
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesityNature, 2012
- Reducing the Effects of PCR Amplification and Sequencing Artifacts on 16S rRNA-Based StudiesPLOS ONE, 2011
- Role of the Commensal Microbiota in Normal and Pathogenic Host Immune ResponsesCell Host & Microbe, 2011
- Prebiotic Effects of Wheat Arabinoxylan Related to the Increase in Bifidobacteria, Roseburia and Bacteroides/Prevotella in Diet-Induced Obese MicePLOS ONE, 2011
- Search and clustering orders of magnitude faster than BLASTBioinformatics, 2010
- Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell MonolayersThe Journal of Nutrition, 2009
- Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial TaxonomyApplied and Environmental Microbiology, 2007
- The Front Line of Enteric Host Defense against Unwelcome Intrusion of Harmful Microorganisms: Mucins, Antimicrobial Peptides, and MicrobiotaClinical Microbiology Reviews, 2006